Skip to content

Phase-transited BSA and cyclic-peptide antifouling interface for ultrasensitive PD-L1 detection in undiluted serum

Document Type
Publications · Journal Article
Registered DB
SCIEScopus
Journal Ranking
JCR Q1Scopus Q1
Journal
BIOSENSORS & BIOELECTRONICS313 · 2026
Citation
Web of Science 1Scopus 1
FWCI (Scopus)
0
JCR IF
JCR 2024 10.5
ISSN
0956-5663

Authors

  1. Xia, JunjieFirst authorShanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China
  2. Cao, JiarongShanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China
  3. Pu, JiayingShanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China
  4. Xie, QiangShanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China
  5. Zhu, ZhongzhengTongji Univ, Shanghai Peoples Hosp 10, Dept Oncol, Sch Med, Shanghai 200072, Peoples R China
  6. Koh, KwangnakCorresponding authorPusan Natl Univ, Inst Gen Educ, Busan 609735, South Korea
  7. Chen, HongxiaCorresponding authorShanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China

Abstract

Soluble programmed death-ligand 1 (sPD-L1) is a promising non-invasive biomarker for early cancer diagnosis and immunotherapy monitoring. However, electrochemical detection of sPD-L1 in serum remains challenging due to severe biofouling that compromises sensitivity and specificity. We developed a one-step, dual-antifouling electrochemical interface by co-assembling phase-transited bovine serum albumin (PTB) and a cyclic multifunctional peptide (CP). PTB forms a dense, amyloid-like nanofilm that acts as a robust protein shield, while CP introduces a zwitterionic antifouling loop and a PD-L1-binding motif. This synergistic architecture significantly suppresses non-specific protein adsorption while enabling oriented target recognition. The sensor achieves a detection limit of 37.4 pg/mL and accurately distinguishes cancer patients from healthy individuals using neat serum without dilution or pretreatment. The PTB/CP dual-antifouling platform offers a simple, sensitive, and clinically translatable strategy for sPD-L1 detection, with broad potential for point-of-care cancer diagnostics and immune monitoring.

Keywords

Cyclic-peptideDual-antifoulingelectrochemicalPD-L1Phase-transited BSA

Identifiers

Scopus EID
2-s2.0-105046927636
WoS UID
001849562700001